Semi-Annual Consolidated Statement Of Cash Flows

Genky DrugStores Co., Ltd. - Filing #7308600

Concept As at
2024-06-20
2023-06-21 to
2024-06-20
As at
2023-06-20
2022-06-21 to
2023-06-20
As at
2022-06-20
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
15,249,000,000 JPY
10,878,000,000 JPY
Interest and dividends received
7,000,000 JPY
8,000,000 JPY
Interest paid
-105,000,000 JPY
-71,000,000 JPY
Income taxes paid
-1,792,000,000 JPY
-2,042,000,000 JPY
Net cash provided by (used in) operating activities
13,256,000,000 JPY
8,773,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-10,278,000,000 JPY
-9,891,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
75,000,000 JPY
Purchase of investment securities
-5,000,000 JPY
JPY
Proceeds from sale of investment securities
2,000,000 JPY
JPY
Other, net
-36,000,000 JPY
49,000,000 JPY
Net cash provided by (used in) investing activities
-10,631,000,000 JPY
-9,736,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
10,356,000,000 JPY
11,053,000,000 JPY
Repayments of long-term borrowings
-12,047,000,000 JPY
-9,799,000,000 JPY
Purchase of treasury shares
0 JPY
0 JPY
Dividends paid
-380,000,000 JPY
-379,000,000 JPY
Net cash provided by (used in) financing activities
-2,058,000,000 JPY
854,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
0 JPY
0 JPY
Net increase (decrease) in cash and cash equivalents
566,000,000 JPY
-108,000,000 JPY
Cash and cash equivalents
5,896,000,000 JPY
5,329,000,000 JPY
5,438,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.